Clinical Trial of Miltefosine to Treat Mucosal Leishmaniasis
Status:
Completed
Trial end date:
2014-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether miltefosine is effective in the treatment
of mucosal leishmaniasis compared to meglumine antimoniate, the standard treatment.